VASOPRESSIN INJECTI
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Defense Logistics Agency award SPE2DP26F6463 is a delivery order issued on June 9, 2026, to DMS Pharmaceutical Group Inc under the base administrative contract SPE2DX25D9900. This procurement, managed by the DLA Troop Support Medical Supply Chain, is for the acquisition of Vasopressin Injectable, identified by NSN 6505015242691. The order specifies a quantity of 309 units with a total contract price of 185.13 dollars. The contract falls under NAICS code 424210 and requires delivery to the Medical Logistics facility at Fort Bragg, North Carolina, by June 24, 2026. This action is part of a broader administrative structure that replaces previous contract SPE2DX25D9383 and incorporates standard federal acquisition regulations, including FAR 52.222-50.
General Info
Contract Value
$185.13Place of Performance
IL, USASet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
